← FDA DRUG APPROVALS

FDA ANDA · ANDA088383

SOMOPHYLLIN-CRT

Sponsor: GRAHAM DM

APPLICATION
ANDA088383
TYPE
ANDA
ORIGINAL APPROVAL
1997-03-14
LATEST ACTION
1997-03-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Discontinued

Products

SOMOPHYLLIN-CRTDiscontinued
THEOPHYLLINE 300MG · CAPSULE, EXTENDED RELEASE · ORAL

Approval history

1997-03-14Labeling · Supplement 9AP
1997-03-14Labeling · Supplement 21AP
1997-03-14Labeling · Supplement 13AP
1997-03-14Labeling · Supplement 6AP
1997-03-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →